Louis Renaud, Satia Imran, Ojanguren Inigo, Schleich Florence, Bonini Matteo, Tonia Thomy, Rigau David, Ten Brinke Anne, Buhl Roland, Loukides Stelios, Kocks Janwillem W H, Boulet Louis-Philippe, Bourdin Arnaud, Coleman Courtney, Needham Karen, Thomas Mike, Idzko Marco, Papi Alberto, Porsbjerg Celeste, Schuermans Daniel, Soriano Joan B, Usmani Omar S
Dept of Pneumology, CHU Liege, GIGA I Research Group, University of Liege, Liege, Belgium.
Taskforce chair.
Eur Respir J. 2022 Sep 7;60(3). doi: 10.1183/13993003.01585-2021. Print 2022 Sep.
Although asthma is very common, affecting 5-10% of the population, the diagnosis of asthma in adults remains a challenge in the real world, which results in both over- and under-diagnosis. A taskforce was set up by the European Respiratory Society to systematically review the literature on the diagnostic accuracy of tests used to diagnose asthma in adult patients and provide recommendations for clinical practice.The taskforce defined eight Population, Index, Comparator and Outcome questions that were assessed using the Grading of Recommendations, Assessment, Development and Evaluation approach. The taskforce utilised the outcomes to develop an evidence-based diagnostic algorithm, with recommendations for a pragmatic guideline for everyday practice that was directed by real-life patient experiences.The taskforce supports the initial use of spirometry followed by bronchodilator reversibility testing (if airway obstruction is present). If initial spirometry fails to show obstruction, further tests should be performed in the following order: exhaled nitric oxide fraction, peak expiratory flow variability, or, in secondary care, bronchial challenge. We present the thresholds for each test that are compatible with a diagnosis of asthma in the presence of current symptoms.The taskforce reinforces spirometry as a priority and recognises the value of measuring blood eosinophils and serum immunoglobulin E to phenotype the patient. Measuring gas trapping by body plethysmography in patients with preserved forced expiratory volume in 1 s/forced vital capacity ratio deserves further attention. The taskforce draws attention to the difficulty of making a correct diagnosis in patients already receiving inhaled corticosteroids; the comorbidities that may obscure diagnosis; the importance of phenotyping; and the necessity of considering the patient experience in the diagnostic process.
尽管哮喘非常常见,影响着5%-10%的人口,但在现实世界中,成人哮喘的诊断仍然是一项挑战,这导致了诊断过度和诊断不足的情况。欧洲呼吸学会成立了一个特别工作组,系统地回顾用于诊断成年患者哮喘的测试的诊断准确性的文献,并为临床实践提供建议。该特别工作组定义了八个“人群、指标、对照和结果”问题,并使用推荐分级、评估、制定和评价方法进行评估。该特别工作组利用这些结果制定了一种基于证据的诊断算法,并针对基于现实患者体验指导日常实践的实用指南提出了建议。该特别工作组支持首先使用肺活量测定法,随后进行支气管扩张剂可逆性测试(如果存在气道阻塞)。如果初始肺活量测定法未显示阻塞,则应按以下顺序进行进一步测试:呼出一氧化氮分数、呼气峰值流速变异性,或者在二级医疗保健中进行支气管激发试验。我们给出了在当前有症状的情况下与哮喘诊断相符的每项测试的阈值。该特别工作组强调肺活量测定法是优先事项,并认识到测量血液嗜酸性粒细胞和血清免疫球蛋白E以对患者进行表型分析的价值。对于1秒用力呼气容积/用力肺活量比值正常的患者,通过体容积描记法测量气体潴留值得进一步关注。该特别工作组提请注意在已经接受吸入性糖皮质激素治疗的患者中做出正确诊断的困难;可能掩盖诊断的合并症;表型分析的重要性;以及在诊断过程中考虑患者体验的必要性。